Metabolic restaging of hepatocellular carcinoma using whole-body 18F-FDG PET/CT

doi:10.4254/wjh.v1.i1.90

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6109)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

511

HTML

4858

Figures (1-4)

421

Tables (1-2)

319

Sum=6109

Oct 31, 2009 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Hepatol. Oct 31, 2009; 1(1): 90-97
Published online Oct 31, 2009. doi: 10.4254/wjh.v1.i1.90

Full Size Figure Download Figure

Figure 3 A 55-year woman suffering from HCC received TACE treatment. Extrahepatic metastases (arrows, A) were detected by PET and PET/CT fused images. Highly metabolic new recurrent lesion of the right lobe (arrows, B-D) and a resident lesion of the left lobe (arrows, E, F) were detected by PET/CT fused imaging. Contrast-enhanced CT follow-up after 1 mo later confirmed the progression of lesions.

Citation: Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H. Metabolic restaging of hepatocellular carcinoma using whole-body ¹⁸F-FDG PET/CT. World J Hepatol 2009; 1(1): 90-97
URL: https://www.wjgnet.com/1948-5182/full/v1/i1/90.htm
DOI: https://dx.doi.org/10.4254/wjh.v1.i1.90